Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Global X Management CO LLC | UROY Uranium Royalty Corp. | 13G/A | 5.74% | Mar 31, 2026 | 6mo |
| Redmile Group, LLC | SRRK Scholar Rock Holding Corp | 13G/A | 7.6% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | CNGL Canna-Global Acquisition Corp. Class A Common Stock | 13G/A | 19.18% | Mar 31, 2026 | 6mo |
| CVI Investments, Inc. | SCYX Scynexis Inc | 13G/A | 6.2% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | PLNT Planet Fitness, Inc. | 13G/A | 3.7% | Mar 31, 2026 | 6mo |
| DISCIPLINED GROWTH INVESTORS INC /MN | KRNT Kornit Digital Ltd. | 13G/A | 6.5% | Mar 31, 2026 | 6mo |
| TD SECURITIES (USA) LLC | MDRX Veradigm Inc. Common Stock | 13G/A | 6.9% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | IR Ingersoll Rand Inc. | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | ELVN Enliven Therapeutics, Inc. | 13G/A | 5.4% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | ALGS Aligos Therapeutics, Inc. | 13G/A | 4.4% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | COLL Collegium Pharmaceutical, Inc | 13G | 5.8% | Mar 31, 2026 | 6mo |
| 1607 Capital Partners, LLC | IGI Western Asset Investment Grade Opportunity Trust Inc. | 13G/A | 6.79% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | CSHR CoinShares PLC | 13G | 5.97% | Mar 31, 2026 | 6mo |
| CITADEL ADVISORS LLC | ALLO Allogene Therapeutics, Inc. | 13G/A | 2.8% | Mar 31, 2026 | 6mo |
| Squadron Capital Management LLC | TRAW Traws Pharma, Inc. | 13G/A | 6.4% | Mar 31, 2026 | 6mo |
| TURTLE CREEK ASSET MANAGEMENT INC. | ATS ATS Corp | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Avoro Capital Advisors LLC | CNTA Centessa Pharmaceuticals plc | 13G/A | 7.39% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | AIG American International Group, Inc. | 13G | 5.3% | Mar 31, 2026 | 6mo |
| Divisadero Street Capital Management, LP | BBW Build-A-Bear Workshop Inc | 13G/A | 7.9% | Mar 31, 2026 | 6mo |
| BROWN ADVISORY INC | ANDG Andersen Group Inc. | 13G/A | 19.89% | Mar 31, 2026 | 6mo |
| TENOR CAPITAL MANAGEMENT Co., L.P. | FACT FACT II Acquisition Corp. | 13G/A | 8.1% | Mar 31, 2026 | 6mo |
| Deep Track Capital, LP | APLS Apellis Pharmaceuticals, Inc. | 13G/A | 3.55% | Mar 31, 2026 | 6mo |
| Greenhouse Funds LLLP | MCW Mister Car Wash, Inc. | 13G/A | 4.1% | Mar 31, 2026 | 6mo |
| Joe Hayon | QTEX QTREX Quantum Ltd. | 13G/A | 5.7% | Mar 31, 2026 | 6mo |
| TD SECURITIES (USA) LLC | HTZ Hertz Global Holdings, Inc | 13G/A | 8.1% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | NERV Minerva Neurosciences, Inc. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| Bain Capital Life Sciences Opportunities IV, L.P. | OLMA Olema Oncology, Inc. | 13G/A | 8.15% | Mar 31, 2026 | 6mo |
| Cormorant Asset Management, LP | RAPP Rapport Therapeutics, Inc. | 13G/A | 6.19% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | MEI Methode Electronics Inc | 13G | 5.6% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | BLFY Blue Foundry Bancorp | 13G | 5.25% | Mar 31, 2026 | 6mo |
| Global X Management CO LLC | UUUU Energy Fuels Inc | 13G/A | 6.83% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | HUBG Hub Group, Inc. | 13G/A | 11.5% | Mar 31, 2026 | 6mo |
| CVI Investments, Inc. | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| Caligan Partners LP | LBRX Lb Pharmaceuticals Inc | 13G | 5% | Mar 31, 2026 | 6mo |
| Saba Capital Management, L.P. | WENN WEN Acquisition Corp | 13G/A | 6.6% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | PTLO Portillo's Inc. | 13G/A | 9.8% | Mar 31, 2026 | 6mo |
| VIKING GLOBAL INVESTORS LP | CHWY Chewy, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | USAR USA Rare Earth, Inc. | 13G/A | 7.6% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | CHGA Change Agents Corporation. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| Deep Track Capital, LP | NRIX Nurix Therapeutics, Inc. | 13G/A | 6.17% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | TREX Trex Co Inc | 13G/A | 8% | Mar 31, 2026 | 6mo |
| TD SECURITIES (USA) LLC | CAEP Cantor Equity Partners III, Inc. | 13G/A | 5% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | PNFP Pinnacle Financial Partners, Inc. | 13G | 6% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | UPWK Upwork, Inc | 13G/A | 13.4% | Mar 31, 2026 | 6mo |
| BCLS Fund III Investments, LP | HTFL Heartflow, Inc. | 13G/A | 12.18% | Mar 31, 2026 | 6mo |
| Woodline Partners LP | TNGX Tango Therapeutics, Inc. | 13G/A | 5.6% | Mar 31, 2026 | 6mo |
| Broad Bay Capital Management, LP | BATRA Atlanta Braves Holdings, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| Berkshire Hathaway Inc | POOL Pool Corp | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Winklevoss Capital Fund, LLC | EMPD Empery Digital Inc. | 13G | 7.9% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | SNDX Syndax Pharmaceuticals Inc | 13G/A | 2.3% | Mar 31, 2026 | 6mo |